Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana

Background: Natural products are used in the production of therapeutic drugs due to their wide diversity and excellent adaptability to biological structures. Sesquiterpene ¡aciones are the active constituents of several plants from the Asteraceae family. Aim: To assess the in vitro effect of a sesqu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dupuy L,Ornar A, Murillo,Renato, Bonilla V,José A
Lenguaje:Spanish / Castilian
Publicado: Sociedad Médica de Santiago 2008
Materias:
Acceso en línea:http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000100008
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:scielo:S0034-98872008000100008
record_format dspace
spelling oai:scielo:S0034-988720080001000082008-04-30Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humanaDupuy L,Ornar AMurillo,RenatoBonilla V,José A Immunosuppression Lymphocytes Sesquiterpenes Background: Natural products are used in the production of therapeutic drugs due to their wide diversity and excellent adaptability to biological structures. Sesquiterpene ¡aciones are the active constituents of several plants from the Asteraceae family. Aim: To assess the in vitro effect of a sesquiterpene lactone (millerenolide). Material and methods: The drug effect was assessed measuring the proliferation of lymphocytes using the 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonylJ-2H-tetrazolium hydroxide (XTT) technique. Changes on the cell cycle were analyzed on a FACSort flow cytometer The effect of millerenolide on the production of nitric oxide (NO) by macrophages was evaluated using the Griess reagent. Additionally, phagocytosis of latex particles and nitroblue tetrazolium (NBT) reduction by macrophages were evaluated microscopically. Results: Treatment of human peripheral blood mononuclear cells (PBMC) with millerenolide decreases the proliferation of lymphocytes, decreases the percentage of cells in S, and G2/Mphases, and increases the proportion of cells in GO/Gl phase. Treatment of macrophages with millerenolide, reduces the production of NO, the phagocytic capacity and the number of cells able to reduce NBT. Cytotoxic effects of the lactone on human PBMC were only observed when the concentration was increased to 6 fig/ml. Conclusions: Millerenolide could be considered as a potential therapeutic agent with immunosuppressiveproperties (RevMéd Chile 2007; 135: 64-72)info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.136 n.1 20082008-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000100008es10.4067/S0034-98872008000100008
institution Scielo Chile
collection Scielo Chile
language Spanish / Castilian
topic Immunosuppression
Lymphocytes
Sesquiterpenes
spellingShingle Immunosuppression
Lymphocytes
Sesquiterpenes
Dupuy L,Ornar A
Murillo,Renato
Bonilla V,José A
Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
description Background: Natural products are used in the production of therapeutic drugs due to their wide diversity and excellent adaptability to biological structures. Sesquiterpene ¡aciones are the active constituents of several plants from the Asteraceae family. Aim: To assess the in vitro effect of a sesquiterpene lactone (millerenolide). Material and methods: The drug effect was assessed measuring the proliferation of lymphocytes using the 2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonylJ-2H-tetrazolium hydroxide (XTT) technique. Changes on the cell cycle were analyzed on a FACSort flow cytometer The effect of millerenolide on the production of nitric oxide (NO) by macrophages was evaluated using the Griess reagent. Additionally, phagocytosis of latex particles and nitroblue tetrazolium (NBT) reduction by macrophages were evaluated microscopically. Results: Treatment of human peripheral blood mononuclear cells (PBMC) with millerenolide decreases the proliferation of lymphocytes, decreases the percentage of cells in S, and G2/Mphases, and increases the proportion of cells in GO/Gl phase. Treatment of macrophages with millerenolide, reduces the production of NO, the phagocytic capacity and the number of cells able to reduce NBT. Cytotoxic effects of the lactone on human PBMC were only observed when the concentration was increased to 6 fig/ml. Conclusions: Millerenolide could be considered as a potential therapeutic agent with immunosuppressiveproperties (RevMéd Chile 2007; 135: 64-72)
author Dupuy L,Ornar A
Murillo,Renato
Bonilla V,José A
author_facet Dupuy L,Ornar A
Murillo,Renato
Bonilla V,José A
author_sort Dupuy L,Ornar A
title Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
title_short Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
title_full Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
title_fullStr Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
title_full_unstemmed Actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
title_sort actividad supresora del millerenólido sobre células mononucleares de sangre periférica humana
publisher Sociedad Médica de Santiago
publishDate 2008
url http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872008000100008
work_keys_str_mv AT dupuylornara actividadsupresoradelmillerenolidosobrecelulasmononuclearesdesangreperifericahumana
AT murillorenato actividadsupresoradelmillerenolidosobrecelulasmononuclearesdesangreperifericahumana
AT bonillavjosea actividadsupresoradelmillerenolidosobrecelulasmononuclearesdesangreperifericahumana
_version_ 1718436357905317888